Journal
CLINICAL & TRANSLATIONAL IMMUNOLOGY
Volume 3, Issue -, Pages -Publisher
WILEY
DOI: 10.1038/cti.2014.4
Keywords
immunity; leishmania; parasites; vaccines
Categories
Funding
- Australian NHMRC
- Australia-India Strategic Research Fund
Ask authors/readers for more resources
Leishmaniasis is a parasitic disease that encompasses a range of clinical manifestations affecting people in tropical and subtropical regions of the world. Epidemiological and experimental data indicate that protection from disease can be achieved in most people. In addition, we know how the host immune system must respond to infection in order to control parasite growth. However, there is still no vaccine for use in humans. Here, we review our understanding of host immunity following Leishmania infection and also discuss recent advances in the development of vaccines to prevent leishmaniasis, highlighting a new promising approach that targets the parasite hemoglobin receptor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available